Atrial Fibrillation clinical trials at UCSD
3 in progress, 1 open to eligible people
Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study
open to eligible people ages 18-100
This is a prospective, non-randomized, multi-center, real-world post-market study to collect and evaluate data regarding the performance of the enhanced atrial fibrillation detection algorithm of the Assert-IQTM Implantable Cardiac Monitor (ICM) device.
San Diego, California and other locations
Conventional Ablation With or Without Focal Impulse and Rotor Modulation to Eliminate Human AF
Sorry, not currently recruiting here
This prospective randomized study will assess the safety and efficacy of FIRM-guided ablation (FIRM+PVI) compared to pulmonary vein isolation (PVI) without FIRM, for the treatment of symptomatic atrial fibrillation.
San Diego, California and other locations
iCLAS™ for Persistent Atrial Fibrillation
Sorry, in progress, not accepting new patients
Clinical study to evaluate the safety and efficacy of the Adagio AF Cryoablation System (iCLAS™) in the ablation treatment of symptomatic, persistent atrial fibrillation (PsAF). Data will be used to support a pre-market application (PMA)
San Diego, California and other locations
Our lead scientists for Atrial Fibrillation research studies include Ulrika Birgersdotter-Green.
Last updated: